Barauskaite-Sarkiniene N, Novickij V, Satkauskas S, Ruzgys P
Int J Mol Sci. 2025; 26(5).
PMID: 40076917
PMC: 11900407.
DOI: 10.3390/ijms26052297.
Skalickova M, Hadrava Vanova K, Uher O, Leischner Fialova J, Petrlakova K, Masarik M
Front Immunol. 2025; 15:1479483.
PMID: 39850897
PMC: 11754201.
DOI: 10.3389/fimmu.2024.1479483.
Ostoich P
Int J Mol Sci. 2025; 26(1.
PMID: 39796112
PMC: 11719969.
DOI: 10.3390/ijms26010257.
Cheng D, Luo L, Zhang Q, Song Z, Zhan Y, Tu W
Adv Sci (Weinh). 2024; 12(6):e2411739.
PMID: 39679909
PMC: 11809400.
DOI: 10.1002/advs.202411739.
Ibanez B, Melero A, Montoro A, San Onofre N, Soriano J
Curr Issues Mol Biol. 2024; 46(11):12718-12732.
PMID: 39590349
PMC: 11592695.
DOI: 10.3390/cimb46110755.
Immunological effects of radiopharmaceutical therapy.
Shea A, Idrissou M, Torres A, Chen T, Hernandez R, Morris Z
Front Nucl Med. 2024; 4:1331364.
PMID: 39355211
PMC: 11440989.
DOI: 10.3389/fnume.2024.1331364.
First independent validation of the proton-boron capture therapy concept.
Jelinek Michaelidesova A, Kundrat P, Zahradnicek O, Danilova I, Pachnerova Brabcova K, Vachelova J
Sci Rep. 2024; 14(1):19264.
PMID: 39164312
PMC: 11335746.
DOI: 10.1038/s41598-024-69370-y.
Imaging-guided companion diagnostics in radiotherapy by monitoring APE1 activity with afterglow and MRI imaging.
Yue R, Li Z, Liu H, Wang Y, Li Y, Yin R
Nat Commun. 2024; 15(1):6349.
PMID: 39068156
PMC: 11283504.
DOI: 10.1038/s41467-024-50688-0.
Low-Dose Ionizing Radiation Exposure on Human Male Gametes: Damage or Benefit.
Dimitrova T, Hristova E, Petrova N
Life (Basel). 2024; 14(7).
PMID: 39063584
PMC: 11277789.
DOI: 10.3390/life14070830.
Sensitize Tumor Immunotherapy: Immunogenic Cell Death Inducing Nanosystems.
Peng J, Li S, Ti H
Int J Nanomedicine. 2024; 19:5895-5930.
PMID: 38895146
PMC: 11184231.
DOI: 10.2147/IJN.S457782.
Efficient Induction of Apoptosis in Lung Cancer Cells Using Bismuth Sulfide Nanoparticles.
Nasehi L, Rezaeejam H, Danafar H, Mirzaghavami P, Mohammadi A, Delshad M
Iran J Biotechnol. 2024; 22(1):e3629.
PMID: 38827339
PMC: 11139445.
DOI: 10.30498/ijb.2024.385844.3629.
The impact of dose rate on responses of human lens epithelial cells to ionizing irradiation.
Matsuya Y, Sato T, Yachi Y, Date H, Hamada N
Sci Rep. 2024; 14(1):12160.
PMID: 38802452
PMC: 11130169.
DOI: 10.1038/s41598-024-62679-8.
Quantification of biochemical PSA dynamics after radioligand therapy with [Lu]Lu-PSMA-I&T using a population pharmacokinetic/pharmacodynamic model.
Siebinga H, de Wit-van der Veen B, de Vries-Huizing D, Vogel W, Hendrikx J, Huitema A
EJNMMI Phys. 2024; 11(1):39.
PMID: 38656678
PMC: 11043318.
DOI: 10.1186/s40658-024-00642-2.
ATR signaling controls the bystander responses of human chondrosarcoma cells by promoting RAD51-dependent DNA repair.
Luong N, Kawamura H, Ikeda H, Roppongi R, Shibata A, Hu J
Int J Radiat Biol. 2024; 100(5):724-735.
PMID: 38442236
PMC: 11060906.
DOI: 10.1080/09553002.2024.2324479.
Cell Death, by Any Other Name….
Kandouz M
Cells. 2024; 13(4.
PMID: 38391938
PMC: 10886887.
DOI: 10.3390/cells13040325.
A novel bystander effect in tamoxifen treatment: PPIB derived from ER+ cells attenuates ER- cells via endoplasmic reticulum stress-induced apoptosis.
Yang T, Li W, Zhou J, Xu M, Huang Z, Ming J
Cell Death Dis. 2024; 15(2):147.
PMID: 38360722
PMC: 10869711.
DOI: 10.1038/s41419-024-06539-3.
Pros and Cons of Alpha versus Beta Bone Seeking Agents in the Treatment of Cancer Pain.
Liepe K
World J Nucl Med. 2023; 22(4):255-256.
PMID: 38152106
PMC: 10751140.
DOI: 10.1055/s-0043-1774731.
Human Intestinal Organoids and Microphysiological Systems for Modeling Radiotoxicity and Assessing Radioprotective Agents.
Bouges E, Segers C, Leys N, Lebeer S, Zhang J, Mastroleo F
Cancers (Basel). 2023; 15(24).
PMID: 38136404
PMC: 10741417.
DOI: 10.3390/cancers15245859.
Combining spatially fractionated radiation therapy (SFRT) and immunotherapy opens new rays of hope for enhancing therapeutic ratio.
Lu Q, Yan W, Zhu A, Tubin S, Mourad W, Yang J
Clin Transl Radiat Oncol. 2023; 44:100691.
PMID: 38033759
PMC: 10684810.
DOI: 10.1016/j.ctro.2023.100691.
Radiotherapy combined with nano-biomaterials for cancer radio-immunotherapy.
Dong Q, Xue T, Yan H, Liu F, Liu R, Zhang K
J Nanobiotechnology. 2023; 21(1):395.
PMID: 37899463
PMC: 10614396.
DOI: 10.1186/s12951-023-02152-2.